MMED · MiniMed Group, Inc.
Price & Indicators
The closing range uses available history since Mar 6, 2026; less than a full year is stored.
Up next
Metrics snapshot
Useful current figures from the complete screener profile.
AI Brief
Q1 FY26 earnings call · Sep 1, 2026TL;DR. MiniMed delivered Q1 FY27 net sales of $843 million, up 16.6% reported and 15.8% organic, with U.S. growth accelerating to 13.1% on the MiniMed Flex launch and international growth of 18.1%. The company raised its FY27 organic revenue growth guidance to ~10.5% from ~10% and reaffirmed ~16% adjusted EBITDA margin guidance, while advancing multiple pipeline programs ahead of schedule.
- + Q1 net sales grew 15.8% organic to $843 million, ahead of expectations
- + U.S. growth accelerated to 13.1% with NPS up over 20% year-over-year on MiniMed Flex
- + International net sales grew 18.1% reported on Simplera capacity and Instinct launch
- + FY27 organic revenue growth guidance raised to ~10.5% from ~10%
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders SellIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA non-GAAP | $83M | Three Months Ended July 31, 2026 filing | — |
| Adjusted Gross Profit non-GAAP | $471M | Three Months Ended July 31, 2026 filing | — |
| Global CGM Attachment Rate | 69% | Three Months Ended July 31, 2026 filing | — |
| New Pumps Sold (in thousands) | 34K | Three Months Ended July 31, 2026 filing | — |
| Organic Revenue Growth non-GAAP | 15.8% | Three Months Ended July 31, 2026 filing | — |
| Worldwide CGM Attachment Rate | 69% | Q1 FY2027 | — |
| Worldwide New Pumps Sold (NPS) | 34,000 | Q1 FY2027 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Medical Instruments & Supplies — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
MMED
this stock
MiniMed Group, Inc.
|
$5.54B | — | — | — | 6.5% |
|
ISRG
Intuitive Surgical Inc
|
$149.78B | -25.1% | +20.5% | 48.7 | 2.1% |
|
BDX
Becton Dickinson & Co
|
$50.05B | — | +8.2% | — | 3.6% |
|
MDLN
Medline Inc.
|
$47.67B | -13.7% | +11.5% | — | 4.0% |
|
RMD
Resmed Inc
|
$33.19B | -4.5% | +13.4% | 22.1 | 8.9% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| MMED | +0.1% | -12.4% | +42.7% | +1.2% | — |
| SPY | +1.2% | +1.9% | +9.9% | +2.1% | +14.2% |
| vs SPY | -1.1% | -14.3% | +32.9% | -0.9% | — |